Published in Am J Cardiol on April 15, 1992
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med (1991) 13.91
Human blood pressure determination by sphygmomanometry. Circulation (1993) 7.88
Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology (2006) 5.67
Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation (2000) 4.12
The effects of explicit timing and feedback on compositional response rate in elementary school children. J Appl Behav Anal (1974) 3.56
Public health informatics: how information-age technology can strengthen public health. Annu Rev Public Health (1995) 3.10
Resumption of driving after life-threatening ventricular tachyarrhythmia. N Engl J Med (2001) 2.89
Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone. Circulation (1992) 2.43
Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors. J Virol (1998) 2.40
Is screening for tuberculosis acceptable to immigrants? A qualitative study. J Public Health (Oxf) (2006) 2.28
Hemidiaphragmatic paresis during interscalene brachial plexus block: effects on pulmonary function and chest wall mechanics. Anesth Analg (1992) 1.99
Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation (1996) 1.94
Molecular determinant of high-affinity dofetilide binding to HERG1 expressed in Xenopus oocytes: involvement of S6 sites. Mol Pharmacol (2000) 1.89
Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation (2001) 1.82
Novel gain-of-function mechanism in K(+) channel-related long-QT syndrome: altered gating and selectivity in the HERG1 N629D mutant. Circ Res (2000) 1.81
Maintenance of behavioral change in a cohort of homosexually active men. AIDS (1992) 1.77
Symptom prevalence, characteristics, and distress in AIDS outpatients. J Pain Symptom Manage (1999) 1.68
Post-discharge surgical wound infection surveillance in a provincial hospital: follow-up rates, validity of data and review of the literature. ANZ J Surg (2001) 1.56
The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en. Virology (1998) 1.55
Validation of three myocardial jeopardy scores in a population-based cardiac catheterization cohort. Am Heart J (2001) 1.55
Developmental changes in the delayed rectifier K+ channels in mouse heart. Circ Res (1996) 1.55
Identification of a new fibroblast growth factor receptor, FGFR5. Gene (2001) 1.54
Electrophysiological characterization of an alternatively processed ERG K+ channel in mouse and human hearts. Circ Res (1997) 1.53
Arrhythmogenic right ventricular dysplasia: a generalized cardiomyopathy? Circulation (1983) 1.47
Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the neuraminidase inhibitor 4-guanidino-Neu5Ac2en leads to instability of the enzyme. Virology (1996) 1.46
Complete heart block and sudden death in mice overexpressing calreticulin. J Clin Invest (2001) 1.43
Osteomyelitis: approaching the 1990s. Med J Aust (1990) 1.42
Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysis. J Am Coll Cardiol (2001) 1.42
Plantar pressure differences between obese and non-obese adults: a biomechanical analysis. Int J Obes Relat Metab Disord (2001) 1.42
'Tea trolley' difficult airway training. Anaesthesia (2015) 1.38
Recurrent haematuria in 17 children. Br Med J (1969) 1.36
Unusual complications of epicardial pacemakers. Recurrent pericarditis, cardiac tamponade and pericardial constriction. Am J Cardiol (1980) 1.36
Developmental changes in transient outward current in mouse ventricle. Circ Res (1997) 1.35
Pain syndromes and etiologies in ambulatory AIDS patients. Pain (1997) 1.35
Thresholds for hearing mistuned partials as separate tones in harmonic complexes. J Acoust Soc Am (1986) 1.34
Temporal patterns in the acoustic signals of beaked whales at Cross Seamount. Biol Lett (2008) 1.30
Coronavirus IBV: virus retaining spike glycopolypeptide S2 but not S1 is unable to induce virus-neutralizing or haemagglutination-inhibiting antibody, or induce chicken tracheal protection. J Gen Virol (1986) 1.30
Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide. Am J Cardiol (1981) 1.28
Preventing recurrent rheumatic fever: the role of register based programmes. Heart (2005) 1.20
Control of endemic MRSA-what is the evidence? A personal view. J Hosp Infect (2004) 1.18
Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol (1982) 1.17
Validation of the acuity card procedure for assessment of infants with ocular disorders. Ophthalmology (1987) 1.16
Thresholds for the detection of inharmonicity in complex tones. J Acoust Soc Am (1985) 1.16
A comparison of the sequences of segment A of four infectious bursal disease virus strains and identification of a variable region in VP2. J Gen Virol (1990) 1.15
Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis. J Urol (1996) 1.15
Transient sinus node dysfunction in acute myocardial infarction associated with the use of a coronary stent. Catheter Cardiovasc Interv (2000) 1.13
Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation. CMAJ (2001) 1.13
Cytogenetic and molecular analysis of inv dup(15) chromosomes observed in two patients with autistic disorder and mental retardation. Am J Med Genet (1996) 1.12
Detection of temporal gaps in sinusoids by elderly subjects with and without hearing loss. J Acoust Soc Am (1992) 1.11
The use of chicken tracheal organ cultures for the isolation and assay of avian infectious bronchitis virus. Arch Virol (1976) 1.10
Clinical predictors of transvenous defibrillation energy requirements. Am J Cardiol (1997) 1.09
A receptor for type I antiarrhythmic drugs associated with rat cardiac sodium channels. Circ Res (1987) 1.09
Deletion of the N-terminus of murine map2 by gene targeting disrupts hippocampal ca1 neuron architecture and alters contextual memory. Neuroscience (2003) 1.09
Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl. Br J Pharmacol (1999) 1.08
Immunodiagnosis of feline immunodeficiency virus infection using recombinant viral p17 and p24. AIDS (1991) 1.08
Complications associated with pectoral cardioverter-defibrillator implantation: comparison of subcutaneous and submuscular approaches. Worldwide Jewel Investigators. J Am Coll Cardiol (1996) 1.08
Complex patterns of inheritance of an imprinted murine transgene suggest incomplete germline erasure. Nucleic Acids Res (2000) 1.07
Pitch discrimination and phase sensitivity in young and elderly subjects and its relationship to frequency selectivity. J Acoust Soc Am (1992) 1.07
Acoustic detections of singing humpback whales (Megaptera novaeangliae) in the eastern North Pacific during their northbound migration. J Acoust Soc Am (1999) 1.06
Taxonomic studies on strains of avian infectious bronchitis virus using neutralisation tests in tracheal organ cultures. Arch Virol (1979) 1.06
Usefulness of noninvasive studies for diagnosis of right ventricular dysplasia. Am J Cardiol (1986) 1.05
A recombinant fowlpox virus expressing the hemagglutinin-neuraminidase gene of Newcastle disease virus (NDV) protects chickens against challenge by NDV. Virology (1990) 1.05
Comparative clinical electrophysiologic effects of diltiazem, verapamil and nifedipine: a review. Am J Cardiol (1982) 1.05
Screening for tuberculosis: the port of arrival scheme compared with screening in general practice and the homeless. Thorax (2002) 1.04
Antibiotic-associated diarrhoea and methicillin-resistant Staphylococcus aureus. Med J Aust (1982) 1.04
Quinidine-induced open channel block of K+ current in rat ventricle. Br J Pharmacol (1995) 1.04
Benefits of linear amplification and multichannel compression for speech comprehension in backgrounds with spectral and temporal dips. J Acoust Soc Am (1999) 1.04
Mitoxantrone for the treatment of advanced breast cancer: single-agent therapy in previously untreated patients. Eur J Cancer Clin Oncol (1984) 1.03
Penicillin tolerance in Streptococcus faecalis. Lancet (1980) 1.03
Prognostic value of infranodal conduction time in patients with chronic bundle branch block. Circulation (1977) 1.01
Late unheralded pacemaker pocket infection due to Staphylococcus epidermidis: a new clinical entity. Pacing Clin Electrophysiol (1982) 1.01
Glucocorticoid regulation of cardiac K+ currents and L-type Ca2+ current in neonatal mice. Circ Res (1999) 1.01
Determinants of stereospecific binding of type I antiarrhythmic drugs to cardiac sodium channels. Mol Pharmacol (1988) 1.01
Methicillin-resistant Staphylococcus aureus bacteraemia. Med J Aust (1981) 1.00
Thermolability of mutant MMACHC protein in the vitamin B12-responsive cblC disorder. Mol Genet Metab (2010) 1.00
Sensing lead failure in implantable defibrillators: a comparison of two commonly used leads. J Cardiovasc Electrophysiol (2000) 1.00
Interaction of ischaemia and encainide/flecainide treatment: a proposed mechanism for the increased mortality in CAST I. Br Heart J (1995) 0.99
Simple modified ultrafiltration. Perfusion (2000) 0.99
Cytokine gene expression in normal human lymphocytes in response to stimulation. Clin Diagn Lab Immunol (1998) 0.97
Atrial pacing periablation for prevention of paroxysmal atrial fibrillation. Circulation (1999) 0.97
Upregulation of the rat cardiac sodium channel by in vivo treatment with a class I antiarrhythmic drug. J Clin Invest (1991) 0.97
A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia. N Engl J Med (1987) 0.96
Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine. Circulation (1983) 0.96
Comparison of dietary risk factors for cardiovascular disease in African-American and white women. J Am Diet Assoc (1997) 0.96
Clinical pharmacokinetics of propafenone. Clin Pharmacokinet (1991) 0.95
Cardiac pacemakers and implantable defibrillators in terminal care. J Pain Symptom Manage (1999) 0.95